Home
Alora Pharmaceutical

Alora Pharmaceutical Market Share Analysis for June 2026

alora pharmaceuticals is an emerging leader in the specialty pharmaceuticals and pharmaceutical manufacturing markets.

Industry: N/A

Domainalorapharma.com

Year Founded2011

Employees501 - 1000

Annual Revenue--

Alora Pharmaceutical

Alora Pharmaceutical (including company regionals)

alorapharma.com

See more website traffic and engagement information

Total visits to Alora Pharmaceutical's top domains

Understand Alora Pharmaceutical market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

alorapharma.com6.6K

See more with Sales Intelligence

Avg. visit duration in Alora Pharmaceutical's top domains

Analyze Alora Pharmaceutical engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

alorapharma.com00:00:20

See more with Sales Intelligence

Avg. pageviews on Alora Pharmaceutical's top domains

See how Alora Pharmaceutical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

alorapharma.com1.66

See more with Sales Intelligence

Alora Pharmaceutical top competitors by domain

Top similar sites in June 2026, ranked by their affinity

alorabh.comCompany NameAlora Behavioral HealthEmployees201 - 500HQUnited States, California, CovinaAnnual revenue--Total visits2.8KN/A

Top technologies used by Alora Pharmaceutical

These are the website technologies, by industry, used by Alora Pharmaceutical top domains

eCommerce (2)

Swap

Email Services (2)

Microsoft Exchange Online

Business Solutions (1)

FreshWorks

Conversion & Analytics (1)

Google Analytics

More Technologies

6

See all

News & Signals from Alora Pharmaceutical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlora Pharmaceuticals, LLC. launches once-daily Relexxii for the treatment of Attention Deficit Hyperactivity Disorder.Alora Pharmaceuticals, LLC announces the availability of once-daily Relexxii(R) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

NewsAlora Pharmaceuticals, LLC. partners with University of New South Wales.Algorae Pharmaceuticals, formerly known as Living Cell Technologies, has entered into a memorandum of understanding (MoU) with the University of New South Wales (UNSW) to collaborate on the development of an artificial intelligence (AI) platform for drug discovery.